MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features
Abstract
Objective: To discuss the diagnostic criteria for Rett syndrome based on mutational screening of the methyl-CpG-binding protein 2 gene ( MECP2 ) in patients with classic Rett syndrome and patients with Rett-like features.
Methods: Thirty-nine patients with classical Rett syndrome, one with preserved speech variant (PSV), and 12 patients with developmental delay and some features of Rett syndrome were recruited for sequence analysis of the MECP2 gene coding region. The phenotype of the patients was correlated with the presence and type of the mutation as well as the X-chromosome inactivation (XCI) pattern.
Results: found in 100% of the patients with classical Rett syndrome originating from Finland. One novel mutation, P127L, was detected in a patient with PSV. No mutations were found in other cases. The XCI status was found to be random in 72% of the patients with classical Rett syndrome, including the patient with PSV and all patients with developmental delay informative for the analysis. Conclusions: An MECP2 mutation can be found in almost every patient with classical Rett syndrome. More patients need to be analyzed in order to clarify the mutation prevalence in patients with atypical Rett syndrome and in patients with mental retardation.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Rett A. Über ein zerebral-atrophisches Syndrome bei Hyperammonemie. Vienna, Austria: Bruder Hollinek, 1966.
2.
Hagberg B, Aicardi J, Dias K, Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann Neurol . 1983; 14: 471–479.
3.
Hagberg B. Introduction. In: Hagberg B, ed. Rett syndrome: clinical and biological aspects. London, UK: Mac Keith Press, 1993: 1–3.
4.
The Rett Syndrome Diagnostic Criteria Work Group. Diagnostic criteria for Rett syndrome. Ann Neurol . 1998; 23: 425–428.
5.
Hagberg B. Clinical criteria, stages and natural history. In: Hagberg B, ed. Rett syndrome: clinical and biological aspects. London, UK: MacKeith Press, 1993: 4–20.
6.
Skjeldal OH, von Tetzchner S, Aspelund F, Herder GA, Lofterld B. Rett syndrome: geographic variation in prevalence in Norway. Brain Dev . 1997; 19: 258–261.
7.
Hagberg B, Hagberg G. Rett syndrome: epidemiology and geographical variability. Eur Child Adolesc Psychiatry . 1997; 6: 5–7.
8.
Ellison KA, Fill CP, Terwilliger J, et al. Examination of X chromosome markers in Rett syndrome: exclusion mapping with a novel variation on multilocus linkage analysis. Am J Hum Genet . 1992; 50: 278–287.
9.
Schanen NC, Dahle EJ, Capozzoli F, et al. A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map. Am J Hum Genet . 1997; 61: 634–641.
10.
Schanen C, Francke U. A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map. Am J Hum Genet . 1998; 63: 267–269.
11.
Sirianni N, Naidu S, Pereira J, Pillotto RF, Hoffman EP. Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am J Hum Genet . 1998; 63: 1552–1558.
12.
Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet . 1999; 23: 185–188.
13.
Wan M, Lee SS, Zhang X, et al. Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet . 1999; 65: 1520–1529.
14.
Kim SJ, Cook EH Jr. Novel de novo nonsense mutation of MECP2 in a patient with Rett syndrome. Hum Mutat 2000;15:382–383.
15.
Xiang F, Buervenich S, Nicolao P, Bailey ME, Zhang Z, Anvret M. Mutation screening in Rett syndrome patients. J Med Genet . 2000; 37: 250–255.
16.
Cheadle JP, Gill H, Fleming N, et al. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location. Hum Mol Genet . 2000; 9: 1119–1129.
17.
Amir RE, Van den Veyver IB, Schultz R, et al. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol . 2000; 47: 670–679.
18.
Huppke P, Laccone F, Kramer N, Engel W, Hanefeld F. Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients. Hum Mol Genet . 2000; 9: 1369–1375.
19.
Bienvenu T, Carrie A, de Roux N, et al. MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet . 2000; 9: 1377–1384.
20.
De Bona C, Zappella M, Hayek G, et al. Preserved speech variant is allelic of classic Rett syndrome. Eur J Hum Genet . 2000; 8: 325–330.
21.
Amano K, Nomura Y, Segawa M, Yamakawa K. Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome. J Hum Genet . 2000; 45: 231–236.
22.
Hampson K, Woods CG, Latif F, Webb T. Mutations in the MECP2 gene in a cohort of girls with Rett syndrome. J Med Genet . 2000; 37: 610–612.
23.
Obata K, Matsuishi T, Yamashita Y, et al. Mutation analysis of the methyl-CpG binding protein 2 gene ( MECP2 ) in patients with Rett syndrome. J Med Genet . 2000; 37: 608–610.
24.
Orrico A, Lam C, Galli L, et al. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett . 2000; 481: 285–288.
25.
Varilo T, Savukoski M, Norio R, et al. The age of human mutation: genealogical and linkage disequilibrium analysis of the CLN5 mutation in the Finnish population. Am J Hum Genet . 1996; 58: 506–512.
26.
Syvänen AC, Ikonen E, Manninen T, et al. Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to aspartylglucosaminuria in Finland. Genomics . 1992; 12: 590–595.
27.
Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet . 1992; 51: 1229–1239.
28.
Pegoraro E, Schimke RN, Arahata K, et al. Detection of new paternal dystrophin gene mutations in isolated cases of dystrophinopathy in females. Am J Hum Genet . 1994; 54: 989–1003.
29.
Nan X, Tate P, Li E, Bird A. DNA methylation specifies chromosomal localization of MECP2 . Mol Cell Biol . 1996; 16: 414–421.
30.
Hagberg B, Gillberg C. Rett variants—Rettoid phenotypes. In: Hagberg B, ed. Rett syndrome: clinical and biological aspects. London, UK: Mac Keith Press, 1993: 40–60.
31.
Meloni I, Bruttini M, Longo I, et al. A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet . 2000; 67: 982–985.
32.
Clayton–Smith J, Watson P, Ramsden S, Black GC. Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet . 2000; 356: 830–832.
33.
Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell . 1997; 89: 349–356.
34.
Nan X, Campoy FJ, Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell . 1997; 88: 471–481.
35.
Jones PL, Veenstra GJ, Wade PA, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet . 1998; 19: 187–191.
36.
Nan X, Ng HH, Johnson CA, et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature . 1998; 393: 386–389.
37.
Nan X, Meehan RR, Bird A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res . 1993; 21: 4886–4892.
38.
Meehan RR, Lewis JD, Bird AP. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res . 1992; 20: 5085–5092.
39.
Pini G, Milan M, Zappella M. Rett syndrome in northern Tuscany (Italy): family tree studies. Clin Genet . 1996; 50: 486–490.
40.
Åkesson HO. Rett syndrome: the Swedish Genealogic Research Project. New data and present position. Eur Child Adolesc Psychiatry . 1997; 6: 96–98.
41.
Peltonen L, Jalanko A, Varilo T. Molecular genetics of the Finnish disease heritage. Hum Mol Genet . 1999; 8: 1913–1923.
Information & Authors
Information
Published In
Copyright
© 2001.
Publication History
Received: August 28, 2000
Accepted: December 12, 2000
Published online: March 13, 2001
Published in print: March 13, 2001
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Autoimmune and neuropsychiatric phenotypes in a Mecp2 transgenic mouse model on C57BL/6 background, Frontiers in Immunology, 15, (2024).https://doi.org/10.3389/fimmu.2024.1370254
- Distributed X chromosome inactivation in brain circuitry is associated with X-linked disease penetrance of behavior, Cell Reports, 43, 4, (114068), (2024).https://doi.org/10.1016/j.celrep.2024.114068
- A catalogue of 863 Rett-syndrome-causing MECP2 mutations and lessons learned from data integration, Scientific Data, 8, 1, (2021).https://doi.org/10.1038/s41597-020-00794-7
- Clinical overview and phenomenology of movement disorders, Principles and Practice of Movement Disorders, (1-51.e27), (2021).https://doi.org/10.1016/B978-0-323-31071-0.00001-9
- Rett Syndrome, Encyclopedia of Autism Spectrum Disorders, (3959-3968), (2021).https://doi.org/10.1007/978-3-319-91280-6_1586
- Rett Syndrome, Atlas of Genetic Diagnosis and Counseling, (2435-2448), (2017).https://doi.org/10.1007/978-1-4939-2401-1_202
- Neurotrophic Factors in the Pathogenesis of Rett Syndrome, Journal of Child Neurology, 18, 10, (693-697), (2016).https://doi.org/10.1177/08830738030180101101
- Rett Syndrome Phenotype Following Infantile Acute Encephalopathy, Journal of Child Neurology, 17, 9, (700-702), (2016).https://doi.org/10.1177/088307380201700910
- X inactivation and reactivation in X-linked diseases, Seminars in Cell & Developmental Biology, 56, (78-87), (2016).https://doi.org/10.1016/j.semcdb.2016.03.009
- Rett Syndrome, Atlas of Genetic Diagnosis and Counseling, (1-14), (2016).https://doi.org/10.1007/978-1-4614-6430-3_202-2
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.